Visits: 1690, Avg visit time (secs): 247,18 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 650 | 38,46% | |
| /msd/efsd-msd-recipients.html | 143 | 8,46% |
| /recipients.html | 98 | 5,80% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 84 | 4,97% |
| /servier/efsd-servier-recipients.html | 46 | 2,72% |
| /gsk/efsd-gsk-recipients.html | 43 | 2,54% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 43 | 2,54% |
| /lilly/efsd-lilly-recipients.html | 37 | 2,19% |
| /new_horizons/recipientsnh.html | 34 | 2,01% |
| /amylin/efsd-amylin-recipients.html | 25 | 1,48% |
| /bms/efsd-bms-recipients.html | 25 | 1,48% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 736 | 43,55% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 106 | 6,27% |
| /new_horizons/recipientsnh.html | 85 | 5,03% |
| /msd/efsd-msd-recipients.html | 56 | 3,31% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 35 | 2,07% |
| /programmes.html | 32 | 1,89% |
| /amylin/efsd-amylin-recipients.html | 29 | 1,72% |
| /novartis/efsd-novartis-recipients.html | 28 | 1,66% |
| /gsk/efsd-gsk-recipients.html | 27 | 1,60% |
| /lilly/efsd-lilly-recipients.html | 26 | 1,54% |
| /servier/efsd-servier-recipients.html | 23 | 1,36% |